Igenbio, Inc. announced today the release of ERGO 2.0, the latest version of a unique integrated platform that enables industrial, academic, and medical scientists to rapidly develop knowledge from existing and new DNA sequencing projects. ERGO 2.0 will help reduce time to market by saving precious lab effort and resources. ERGO 2.0 contains a massive curated database integrated with state of the art synthetic biology tools enabling faster product creation.

October 29, 2014
Eurofins Genomics and Igenbio have announced a co-operation agreement to combine their expertise in sequencing and analysis services for microbial, fungal and algal organisms.

August 19, 2014
Igenbio, Inc., a Chicago based genome analysis company, announced today that they entered into a collaborative agreement with Genome Compiler Corp., a Los Altos based synthetic biology software company.

May 22, 2014
Igenbio, Inc. proudly announces the establishment of an office in Japan and the launch of a Japanese language website.

05/10/2011 Ebersberg, Germany and Mount Prospect, IL, USA

Eurofins MWG Operon and Integrated Genomics have announced a cooperation agreement to combine their expertise in sequencing and analysis services for microbial, fungal and algal organisms.

Arlington Heights, IL (February 9, 2010) Integrated Genomics, Inc., a leader in microbial genomic informatics, is collaborating with Focus Ahead Consulting Ltd. in the UK to represent and market microbial genome sequencing and bioinformatics services in Europe. Integrated Genomics ERGO™ platform is the leading informatics system for microbial systems biology. 

CHICAGO, IL (May 5, 2009) – Integrated Genomics, Inc. today announces it has appointed Jose Laplaza, Ph.D. as Director of Strain Engineering and Lab Operations. Dr. Laplaza brings significant experience in gene expression, fermentation optimization and strain development. He will be responsible for leading IG’s efforts in contract and internal metabolic engineering research. 

(Chicago, IL and Guildford, UK) Integrated Genomics, Inc., a leader in microbial genomic informatics and TMO Renewables Limited, a leader in the production of ethanol from biomass, announced today that they have signed an agreement to extend their collaboration on the discovery of cellulosic bioethanol production systems. 

Chicago, Illinois. Integrated Genomics announced the publication of the complete Granulibacter bethesdensisgenome sequence, the first acetic acid bacteria to be identified as an agent of an emerging invasive human disease.

Cincinnati, OH - Scientists from P&G Beauty announced that they successfully sequenced the complete genome for Malassezia globosa (M. globosa), a naturally occurring fungus responsible for the onset of dandruff and other skin conditions in humans. Results of the genome sequencing are published in the November fifth online edition of Proceedings of the National Academy of Sciences (PNAS).

(Chicago IL, Beverly MA, and Wolfenbüttel Germany) Integrated Genomics Inc. and BIOBASE GmbH announced today that they have signed a collaboration agreement to expand and curate Integrated Genomics' ERGO™ microbial genomic database. BIOBASE scientists in Bangalore, India will add manually-curated functional gene annotations and pathways to the ERGO genomic database. This agreement further expands the custom curation services BIOBASE offers its customers.

(Chicago, IL and Daejeon, South Korea) Korean research Institute of Bioscience and Biotechnology (KRIBB), a world leader in the integrated biotechnology and bioinformatics has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. KRIBB will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as for comparative genomics purposes.

(Chicago, IL and Guildford, UK) TMO Renewables Limited, a leader in the production of ethanol from biomass, has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. TMO will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as comparative genomics. 

New England Biolabs (NEB), a world leader in the production and supply of reagents for the life science industry, has licensed the ERGO™ bioinformatics software developed and maintained by Integrated Genomics. NEB will utilize the ERGO™ genome analysis tools for gene annotation, metabolic reconstruction and enzyme data-mining as well as for comparative genomics purposes. 

CHICAGO, IL - March 14, 2007

Integrated Genomics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the US Environmental Protection Agency (EPA) to develop methods to improve the bio-production of butanol. Currently butanol is produced from petroleum feedstock.

CHICAGO, IL and Oxford, UK - March 6, 2007

Oxford Gene Technology (OGT) and Integrated Genomics (IG) today announced the signing of a collaboration to develop and market a Pichia pastoris Gene Expression (GE) oligonucleotide microarray. The collaboration gives OGT access to IG’s proprietary Pichia pastoris genomic sequence for the design and development of a high quality optimized 60 mer oligonucleotide microarray using the ink jet in-situ synthesis (IJISS) platform. OGT will market the array worldwide, and offer a sample analysis service at its Oxford laboratory.

CHICAGO, IL - February 28, 2007

Integrated Genomics announced today that Genencor, the biotechnology division of Danisco A/S that develops innovative enzymes and bio-products, has licensed the ERGO™ bioinformatics software system to characterize and optimize microbial products used in reducing the environmental impact of the cleaning, textiles, oil and chemical industries. ERGO™ is a powerful software platform for analyzing genome sequences and performing gene annotations, metabolic reconstructions, and other gene analyses and comparisons.

CHICAGO, IL and Stockholm, Sweden - January 29, 2007

Integrated Genomics Inc. (Chicago, IL), a leading provider of microbial gene sequencing and analysis services, has signed an agreement with Arla Foods in Sweden and Denmark to sequence and annotate the genome of a dairy lactic acid bacterium. Scientists at Arla Foods will use the new sequence and metabolic reconstructions in Integrated Genomics’ ERGO™ bioinformatics system to characterize and develop lactic acid bacteria used in foods such as milk, cheese, butter, and milk based products.

CHICAGO, IL and Laguna Hills, CA - January 4, 2007

CODA Genomics and Integrated Genomics (Chicago, IL) announced today a collaboration which will apply CODA’s proprietary Translation Engineering™ protein expression technology to the Pichia yeast expression system.